| Product Code: ETC9217598 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Prophylactic Vaccines Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Prophylactic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Prophylactic Vaccines Market - Industry Life Cycle |
3.4 Serbia Prophylactic Vaccines Market - Porter's Five Forces |
3.5 Serbia Prophylactic Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Serbia Prophylactic Vaccines Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 Serbia Prophylactic Vaccines Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 Serbia Prophylactic Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Serbia Prophylactic Vaccines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Serbia Prophylactic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Serbia |
4.2.2 Growing government initiatives to promote vaccination programs |
4.2.3 Rising prevalence of infectious diseases in Serbia |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas of Serbia |
4.3.2 High cost associated with prophylactic vaccines |
4.3.3 Vaccine hesitancy among certain population segments in Serbia |
5 Serbia Prophylactic Vaccines Market Trends |
6 Serbia Prophylactic Vaccines Market, By Types |
6.1 Serbia Prophylactic Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Serbia Prophylactic Vaccines Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Serbia Prophylactic Vaccines Market Revenues & Volume, By Live/Attenuated Vaccines, 2021- 2031F |
6.1.4 Serbia Prophylactic Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.1.5 Serbia Prophylactic Vaccines Market Revenues & Volume, By Subunit Vaccines, 2021- 2031F |
6.1.6 Serbia Prophylactic Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.1.7 Serbia Prophylactic Vaccines Market Revenues & Volume, By Conjugate Vaccines, 2021- 2031F |
6.1.8 Serbia Prophylactic Vaccines Market Revenues & Volume, By Recombinant Vector Vaccines, 2021- 2031F |
6.2 Serbia Prophylactic Vaccines Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 Serbia Prophylactic Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.2.3 Serbia Prophylactic Vaccines Market Revenues & Volume, By Poliovirus, 2021- 2031F |
6.2.4 Serbia Prophylactic Vaccines Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.2.5 Serbia Prophylactic Vaccines Market Revenues & Volume, By Influenza, 2021- 2031F |
6.2.6 Serbia Prophylactic Vaccines Market Revenues & Volume, By Measles, 2021- 2031F |
6.2.7 Serbia Prophylactic Vaccines Market Revenues & Volume, By Mumps, 2021- 2031F |
6.2.8 Serbia Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.2.9 Serbia Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.3 Serbia Prophylactic Vaccines Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 Serbia Prophylactic Vaccines Market Revenues & Volume, By Intramuscular Route, 2021- 2031F |
6.3.3 Serbia Prophylactic Vaccines Market Revenues & Volume, By Subcutaneous Route, 2021- 2031F |
6.3.4 Serbia Prophylactic Vaccines Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3.5 Serbia Prophylactic Vaccines Market Revenues & Volume, By Intravenous Injection, 2021- 2031F |
6.3.6 Serbia Prophylactic Vaccines Market Revenues & Volume, By Administration Routes, 2021- 2031F |
6.4 Serbia Prophylactic Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Serbia Prophylactic Vaccines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Serbia Prophylactic Vaccines Market Revenues & Volume, By Retail Pharmacy and Online Pharmacy, 2021- 2031F |
6.5 Serbia Prophylactic Vaccines Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Serbia Prophylactic Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Serbia Prophylactic Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Serbia Prophylactic Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 Serbia Prophylactic Vaccines Market Import-Export Trade Statistics |
7.1 Serbia Prophylactic Vaccines Market Export to Major Countries |
7.2 Serbia Prophylactic Vaccines Market Imports from Major Countries |
8 Serbia Prophylactic Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rate in Serbia |
8.2 Number of vaccination campaigns conducted annually |
8.3 Rate of new vaccine introductions in the Serbian market |
9 Serbia Prophylactic Vaccines Market - Opportunity Assessment |
9.1 Serbia Prophylactic Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Serbia Prophylactic Vaccines Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 Serbia Prophylactic Vaccines Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 Serbia Prophylactic Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Serbia Prophylactic Vaccines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Serbia Prophylactic Vaccines Market - Competitive Landscape |
10.1 Serbia Prophylactic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Serbia Prophylactic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here